Research from the Institute for Clinical Evaluative Sciences and the Yale School of Medicine in New Haven, Conn., found overall CT rates in the emergency department (ED) are higher and rising faster in the U.S. compared to the province of Ontario. U.S. patients are nearly twice as likely to undergo a CT scan during an ED visit as Canadians.

The U.S. House of Representatives adopted a resolution June 2 that aims to improve the health of those affected by atrial fibrillation (AF) by promoting enhanced awareness, treatment and diagnoses to help curb mortality. The Heart Rhythm Society and other like stakeholders have applauded the Houses efforts.

An FDA Advisory Panel is scheduled to review Edwards Lifesciences' premarket approval application for its Edwards Sapien transcatheter aortic heart valve on July 20.

Nearly 50 percent of  deaths in Europe are caused by cardiovascular disease (CVD), and CVD management has a price tag of 192 billion ($282 billion U.S.) per year. A new guidance released by the European Atherosclerosis Society Consensus Panel outlined best practices for how to optimally manage triglycerides and HDL cholesterol in CVD patients.

A South Carolina bill requiring the states Department of Health and Environmental Control to identify hospitals that use telemedicine in stoke treatment is slated to hit the governors desk after passing unanimously in both the state House and Senate.

The Society of Nuclear Medicines (SNM) 2011 Image of the Year illustrates the ability of PET/CT scans to identify abnormal bone reaction in patients who have received spinal fixation hardware implants. Researchers selected this image from more than 1,800 studies presented over the course of four days during SNMs 58th annual meeting in San Antonio, Texas.

A potentially practice-changing study suggested that additional radiation treatment (RT) improves disease-free survival, lessening the chance of cancer recurring in women with early breast cancer who have had breast-conserving surgery, according to interim results presented at the annual meeting of the American Society of Clinical Oncology (ASCO).

Biotech company ImaginAb has locked a research deal with GE Healthcare to develop PET diagnostic imaging agents for cardiovascular disease, the companies said on June 5.